Amino acid replacement: S95F.
Nucleotide substitution: C?T.
C19869209T
C?T
S95F | Rab8-PA; S60F | Rab8-PB; S95F | Rab8-PC
S95F
abnormal neuroanatomy | third instar larval stage (with Df(3L)ED228)
abnormal neuroanatomy | third instar larval stage (with Rab81)
abnormal neuroanatomy | third instar larval stage (with Rab83)
abnormal neuroanatomy | third instar larval stage (with Rab8B229)
abnormal neuroanatomy | third instar larval stage (with Rab8Z3007)
lethal - all die during immature adult stage (with Rab81)
embryonic/larval neuromuscular junction | third instar larval stage (with Df(3L)ED228)
embryonic/larval neuromuscular junction | third instar larval stage (with Rab81)
embryonic/larval neuromuscular junction | third instar larval stage (with Rab83)
embryonic/larval neuromuscular junction | third instar larval stage (with Rab8B229)
embryonic/larval neuromuscular junction | third instar larval stage (with Rab8Z3007)
NMJ bouton | third instar larval stage (with Df(3L)ED228)
NMJ bouton | third instar larval stage (with Rab81)
NMJ bouton | third instar larval stage (with Rab83)
NMJ bouton | third instar larval stage (with Rab8B229)
NMJ bouton | third instar larval stage (with Rab8Z3007)
Rab81/Rab82 mutants show pharate lethality.
All the tested trans-heterozygous allelic combinations of Rab82 mutants display synaptic overgrowth, characterized by significant increase in synaptic bouton number of up to 100% relative to wild-type.